Abstract
Late endocytic compartments, containing MHC class II molecules in antigen presenting cells, fuse to each other in order to deliver antigens to these molecules. We have shown previously that fusion of late endocytic compartments takes place also in hybridomas. Therefore, we investigate here whether the level of fused late endocytic compartments affects the immunostimulatory capacity of hybridomas obtained by the electrofusion of dendritic and tumor cells. The level of fused late endocytic compartments in a single hybridoma cell was assessed and samples of electrofused cells were then cocultured with autologous T cells, resulting in the priming of naïve T cells. To test the immunostimulatory capacity of hybridoma cells, T-cell-induced cytotoxicity of tumor cells was assayed. The results demonstrate that in vitro cytotoxic T cell responses are enhanced if a higher percentage of fused late endocytic compartments is present in the cell population of electrofused hybridoma cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergant M, Meden L, Repnik U, Sojar V, Stanisavljević D, Jeras M (2006) Preparation of native and amplified tumour RNA for dendritic cell transfection and generation of in vitro anti-tumour CTL response. Immunobiology 211:179–189
Cresswell P (1996) Invariant chain structure and MHC class II function. Cell 84:505–507
Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES (2005) Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307:1630–1634
Deng Y, Griffiths G, Storrie B (1991) Comparative behavior of late endocytic compartments and the pre-lysosome compartment (PLC) in vivo cell fusion experiments. J Cell Sci 99:571–582
Ferrari G, Knight AM, Watts C, Pieters J (1997) Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules. J Cell Biol 139:1433–1446
Gabrijel M, Kreft M, Zorec R (2008) Monitoring lysosomal fusion in electrofused hybridoma cells. BBA Biomembr 1778:483–490
Galea-Lauri J, Darling D, Mufti G, Harrison P, Farzaneh F (2002) Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol Immunother 51:299–310
Geuze HJ (1998) The role of endosomes and late endocytic compartments in MHC class II functioning. Immunol Today 19:282–287
Kleijmeer MJ, Ossevoort MA, van Veen CJ, van Hellemond JJ, Neefjes JJ, Kast WM, Melief CJ, Geuze HJ (1995) MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells. J Immunol 154:5715–5724
Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY, Geuze HJ (1997) Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol 139:639–649
Kreft M, Zorec R (2005) ParticleCO: particle counting software: user’s guide. Celica, Ljubljana, Slovenia. Available at: http://lnmcp.mf.uni-lj.si/particleCO_guide.pdf
Kreft M, Milisav I, Potokar M, Zorec R (2004) Automated high through-put colocalization analysis of multichannel confocal images. Comput Methods Programs Biomed 74:64–67
Liljedahl M, Kuwana T, Fung-Leung WP, Jackson MR, Peterson PA (1996) HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 15:4817–4824
Mellman I, Turley SJ, Steinman RM (1998) Antigen processing for amateurs and professionals. Trends Cell Biol 8:231–237
Mukherjee P, Dani A, Bhatia S, Singh N, Rudensky AY, George A, Bal V, Mayor S, Rath S (2001) Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis. J Immunol 167:2632–2641
Perou C, Kaplan J (1993) Complementation analyses of the Chediak-Higashi syndrome: the same gene may be responsible for the defect in all patients and species. Somatic Cell Genet 19:459–468
Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ (1991) Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669–676
Rosenblatt J, Kufe D, Avigan D (2005) Dendritic cell fusion vaccines for cancer immunotherapy. Expert Opin Biol Ther 5:703–715
Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L (2002) Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res 62:1884–1889
Trevor KT, Cover C, Ruiz YW, Akporiaye ET, Hersh EM, Landais D, Taylor RR, King AD, Walters RE (2004) Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Cancer Immunol Immunother 53:705–714
Wang Y, Goren MB (1987) Differential and sequential delivery of fluorescent lysosomal probes into phagosomes in mouse peritoneal macrophages. J Cell Biol 104:1749–1754
Acknowledgements
This work was supported by the Slovenian Research Agency. For immune tests address correspondence to M. J.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gabrijel, M., Bergant, M., Kreft, M. et al. Fused Late Endocytic Compartments and Immunostimulatory Capacity of Dendritic–Tumor Cell Hybridomas. J Membrane Biol 229, 11–18 (2009). https://doi.org/10.1007/s00232-009-9171-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-009-9171-7